Month: June 2024

Rescheduling Cannabis and Its Broad Ripple Effects Part 5

Corporate Giants Enter the Arena: Navigating New Economic Challenges in Cannabis Welcome to Part 5 of our comprehensive series, “The New Frontier: Rescheduling Cannabis and Its Broad Ripple Effects.” This installment explores the intricate economic shifts and corporate dynamics unleashed by the rescheduling of cannabis to Schedule III. We examine…
Read More

Rescheduling Cannabis and It’s Broad Ripple Effect Part 4

Rescheduling Cannabis and Its Broad Ripple Effect: Legal Complexities in a New Era of Cannabis Policy Welcome to Part 4 of our enlightening series on the transformative rescheduling of cannabis. As we navigate through the newly charted territories, this installment delves into the intricate legal complexities that accompany the transition…
Read More
rescheduling cannabis

Rescheduling Cannabis and Its Broad Ripple Effects Part 3

Part 3: Harnessing R&D Tax Credit Opportunities Post-Rescheduling Continuing our exploration in Part 3 of “The New Frontier: Rescheduling Cannabis and Its Broad Ripple Effects,” we shift our focus to the Research & Development (R&D) Tax Credit Opportunities that have opened up for the cannabis industry. Research and Development Credit…
Read More

Rescheduling Cannabis and Its Broad Ripple Effects Part 2

Welcome to Part II of our comprehensive series, “The New Frontier: Rescheduling Cannabis and Its Broad Ripple Effects.” In this installment, we explore the significant tax implications resulting from the DEA’s decision to reclassify cannabis as a Schedule III substance. This reclassification ushers in a new fiscal environment for cannabis…
Read More

We understand the importance of approaching each work integrally and believe in the power of simple.

Melbourne, Australia
(Sat - Thursday)
(10am - 05 pm)